Pharmafile Logo

Portcullis Public Affairs

Portcullis Public Affairs is a leading government and communications consultancy, with over 25 years experience offering advice to prominent companies, charities and other organisations in the UK. Health specialisms include public affairs, government relations in the UK and Europe, and crisis management. We help Government reach better decisions. Portcullis is in partnership with MAP BioPharma which helps clients navigate the detailed processes so as to achieve optimal market access in the UK, Ireland and Germany. Together, we provide a unique combination of public affairs capabilities and detailed market analyses.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Company Details

11 Haymarket, London, SW1Y 4BP, United Kingdom
+44 (0)20 7368 3100

 Latest Content from PMHub 

Marketing Automation for Pharma

With Pharma Marketers increasingly being asked to do more with fewer resources, Marketing Automation is a key area that needs to be explored. Find out how it could help you...

Blog the brand builder

This report looks into current practice in B2B marketing communications, the importance of online reputation, and the opportunities offered by social media. It confirms the move online and suggests that...

How to Master Multichannel Marketing in Pharma

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

Press Releases | May 30, 2011 | M3 (EU)

M3, the global healthcare technology company with brands including Doctors.net.uk, medeConnect, M3 Global Research, Rotamaster and The Vidal Group has announced two significant appointments in Paul Rice who joins as...